Scott D Patterson
Celera Corporation
7 Papers
126 Citations
Scott D Patterson is an academic researcher from Celera Corporation. The author has contributed to research in topics: Protein mass spectrometry & Proteomics. The author has an hindex of 6, co-authored 7 publications.
Chat about Author
Papers
Proteomics: the first decade and beyond.
TL;DR: Proteomics and other complementary analysis methods are essential components of the emerging 'systems biology' approach that seeks to comprehensively describe biological systems through integration of diverse types of data and, in the future, to ultimately allow computational simulations of complex biological systems.
796
Patent
Pancreatic cancer targets and uses thereof
Bruno Domon,Ian McCaffery,Vaibhav A. Narayan,Scott D Patterson +3 more
- 06 Aug 2004
TL;DR: In this article, a method for diagnosing and detecting diseases associated with pancreas is presented, where one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAT) and antibodies binds to PCAT.
63
Proteomics: drug target discovery on an industrial scale
Terence E Ryan,Scott D Patterson +1 more
TL;DR: This review identifies the technical issues to be addressed for industrial-scale protein-based discovery in the identification of targets for therapeutic (or diagnostic) intervention and aims to direct discovery in a way that increases the probability of robust target identification, and decreases the likelihood of failure owing to variable expression in this emerging field.
45
Quantitation of phosphopeptides using affinity chromatography and stable isotope labeling
TL;DR: An improved methodology was published that showed increased selectivity through esterification of amino acid side chain carboxylic groups of enzymatically digested peptides and its application to the analysis of the effects of serum starvation on in vitro cultured human lung cells is presented.
37
•Journal Article
Enabling parallel protein analysis through mass spectrometry.
TL;DR: In this review, recent advances in mass spectrometry instrumentation, methods and applications that are likely to impact drug discovery are described.
17